The HESI Immuno-Safety Technical Committee’s humanized mouse project hosted Kristina Howard (FDA), who presented key findings from her SOT 2024 poster entitled “Donor specific toxicity of copanlisib identified using immune-humanized mice”.
Donor Specific Toxicity of Copanlisib Identified Using Immune-Humanized Mice
April 22, 2024
Immuno-Safety Technical Committee, Webinar